These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37705317)

  • 1. Genomic gain/methylation modification/hsa-miR-132-3p increases RRS1 overexpression in liver hepatocellular carcinoma.
    Zhang X; Cong P; Tian L; Zheng Y; Zhang H; Liu Q; Wu T; Zhang Q; Wu H; Huang X; Xiong L
    Cancer Sci; 2023 Nov; 114(11):4329-4342. PubMed ID: 37705317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
    Wu S; Liu S; Cao Y; Chao G; Wang P; Pan H
    Aging (Albany NY); 2022 Mar; 14(5):2304-2319. PubMed ID: 35278064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma.
    Eun JW; Ahn HR; Baek GO; Yoon MG; Son JA; Weon JH; Yoon JH; Kim HS; Han JE; Kim SS; Cheong JY; Kim BW; Cho HJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
    Wang B; Chen L; Li Q; Zhou J; Jin W
    Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma.
    Sun Q; Liu X; Peng Q; Hu L; Jiang X
    J Immunol Res; 2022; 2022():1584397. PubMed ID: 35615532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-381 Reverses Multidrug Resistance by Negative Regulation of the
    Pu B; Yu X; Cao Y; Li Y; Tang L; Xia J
    DNA Cell Biol; 2021 Dec; 40(12):1584-1596. PubMed ID: 34931867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis.
    Ma YS; Chu KJ; Ling CC; Wu TM; Zhu XC; Liu JB; Yu F; Li ZZ; Wang JH; Gao QX; Yi B; Wang HM; Gu LP; Li L; Tian LL; Shi Y; Jiang XQ; Fu D; Zhang XW
    Mol Ther Nucleic Acids; 2020 Sep; 21():229-241. PubMed ID: 32585630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis.
    Feng T; Yao Y; Luo L; Zou H; Xiang G; Wei L; Yang Q; Shi Y; Huang X; Lai C
    Sci Rep; 2023 Jan; 13(1):650. PubMed ID: 36635290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
    Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
    Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa-microRNA-370-3p targeting Snail and Twist1 suppresses IL-8/STAT3-driven hepatocellular carcinoma metastasis.
    Peng S; Chen Y; Li T; Mao J; Yang P; Zou B; Luo L; Zhang W; Wang W; Xie R; Li J; Zeng L
    Cancer Sci; 2022 Dec; 113(12):4120-4134. PubMed ID: 36083239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0000285 knockdown inhibits the progression of hepatocellular carcinoma by sponging miR-582-3p to regulate CCNB2 expression.
    Huang J; Zhou H; Diao Y; Yang Z
    Hum Exp Toxicol; 2022; 41():9603271221115400. PubMed ID: 35839486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
    Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
    Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis.
    Zhan W; Liao X; Chen Z; Li L; Tian T; Yu L; Wang W; Hu Q
    J Cell Physiol; 2020 Feb; 235(2):1733-1745. PubMed ID: 31317555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling.
    Wen J; Huang Z; Wei Y; Xue L; Wang Y; Liao J; Liang J; Chen X; Chu L; Zhang B
    Cell Mol Biol Lett; 2022 Sep; 27(1):79. PubMed ID: 36138344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    He Y; Cui Y; Wang W; Gu J; Guo S; Ma K; Luo X
    Neoplasia; 2011 Sep; 13(9):841-53. PubMed ID: 21969817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
    He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.